Revision Date |
Policy |
3/10/05 12/05/2018
9/14/12 3/14/02
|
Categories of Research - Research Eligible for Exemption (prior to January 21, 2019) - Research Eligible for Exemption (Revised Common Rule, effective January 21, 2019) - Expanded Guide to Exempt Category 3 - Exempt Determination Decision Chart (Revised Common Rule, effective January 21, 2019) - Research Eligible for Expedited Review - Research Requiring Full Board Review
|
1/14/11 |
Cell Line and Dataset Policy |
7/6/13 |
Case Report Policy (Authorization Form) |
6/10/14 (Posted 11/21/14) |
Research Involving Adult Persons with Diminished Capacity |
1/17/18 |
Humanitarian Use Device Policy and Procedure |
3/25/15 |
Reportable Events Policy (replaces Internal Adverse Event Policy, External Adverse Event Policy, and Protocol Deviation Policy and Procedure) |
2/5/10 |
Principal Investigator Requirements |
5/07 |
Research Record Retention Policy |
2/07 |
Participation of Research Personnel as Research Subjects Policy |
3/07 |
Data and Safety Monitoring Policy |
7/12/02 |
Research Involving Psychiatric In-Patients |
12/17/12 |
Amendment Policy and Procedure |
3/7/12 |
Policy on Disclosing Financial Conflicts of Interest to the Einstein IRB |
6/30/15 |
Informed Consent Guidelines |
7/31/16 |
Use of Epic in Research |
9/27/2017 |
Certificate of Confidentiality Policy and Guidance and FAQ |
1/12/01 |
Policy and Procedure for Reporting Protocol Non-Compliance |
11/17/17 |
Required Documentation for the Conduct of Research Involving Human Subjects |
5/21/07 |
Collection and/or Study of Human Specimens Policy |
5/8/03 |
Investigational Drug, Biologic and Device Policy |
5/8/03 |
Emergency Use of an Investigational Drug or Biologic Policy and Procedure |
5/8/03 |
Emergency Use of an Investigational Device Policy and Procedure |
10/12/04 |
Guidelines for Storage and Dispensing of Investigational Drugs |
3/01 |
Compensation Language Policy |
5/12/05 |
Radiation/Radioisotope Guidelines |
2/08 |
Non-Pregnant Women Research Policy |
11/22/13 |
HIV Guidelines |
06/2017 |
Fetal Tissue Research Policy |
2/8/07 |
Pregnant Women or Fetuses Research Policy |
1/24/05 |
Enrollment of Subjects in Significant Pain |
12/6/11 |
Guidelines for the Recording of Research Subjects |
1/08 |
Transportation of Subjects |
9/18/02 |
Advertisement Policy |
12/15/11 |
Guidelines for Compensation of Research Subjects |
12/15/11 |
MMC Research Biling Policy |
10/23/09 |
Inclusion of Children in NIH Research Protocols |
10/23/09 |
NIH Regulations Regarding FDA Correspondence |
5/8/03 |
Enrollment of Minors in Research – Principles and Guidelines |
5/9/14 (Posted 9/30/14) |
Use of Protected Health Information (PHI) in Research (replaces Policy for the Use of Patient Medical Record Information in Research and Recruitment of Research Participants) |
12/6/11 |
Yeshiva University Undergraduate Student and Faculty Research Guidelines |
2/5/10 |
Policy for Informing Research Participants of Protocol Amendments and/or New Risk Information |
8/5/05 |
Placebo-Use and Washout in Psychiatric Research |
1/31/11 |
Policy and Procedure for National Cancer Institute CIRB |
06/28/17 |
Guidelines for registration of studies on ClinicalTrials.gov. Instructions for registering your study are available here. Instructions for updating your registration are available here. FAQs are available here. |
1/13/12 and 04/2017 |
Audit and Inspection Guidelines and Audit Policy |
01/2019 |
Notes on Names for Einstein IRB and Albert Einstein College of Medicine |